Carregant...
Targeting Inflammatory Kinase as an Adjuvant Treatment for Osteosarcomas
BACKGROUND: A subset of patients with aggressive osteosarcomas responds poorly to conventional cytotoxic chemotherapy. Recent evidence from studies involving the liver, skin, stomach, and colon suggests that carcinogenesis is associated with inflammation. Mitogen-activated protein kinase (MAPK)/extr...
Guardat en:
| Publicat a: | J Bone Joint Surg Am |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Journal of Bone and Joint Surgery, Inc.
2011
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6882535/ https://ncbi.nlm.nih.gov/pubmed/21508279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2106/JBJS.J.00302 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|